Corporate News Blog – Philips Inks Agreement with Lakeland Hospital; Set to Implement IntelliVue Guardian Solution

Research Desk Line-up: Energous Post Earnings Coverage

LONDON, UK / ACCESSWIRE / August 17, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Koninklijke Philips N.V. (NYSE: PHG) (“Philips”), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=PHG. The Company announced on August 15, 2017, that it has signed an agreement with Lakeland Health to integrate the Philips IntelliVue Guardian Solution with automated Early Warning Scoring (EWS) at all three of the Lakeland Health’s hospitals. The IntelliVue Guardian Solution from Philips contains software and intelligent clinical decision algorithms enabling caregivers to accurately obtain vital signs and seamlessly integrate validated patient data directly to the EHR, hence reducing human errors and saving time. For immediate access to our complimentary reports, including today’s coverage, register for free now at:

http://protraderdaily.com/register/

Discover more of our free reports coverage from other companies within the Electronic Equipment industry. Pro-TD has currently selected Energous Corporation (NASDAQ: WATT) for due-diligence and potential coverage as the Company announced on August 08, 2017, its financial results for Q2 2017 which ended on June 30, 2017. Tune in to our site to register for a free membership, and be among the early birds that get our report on Energous when we publish it.

At Pro-TD, we make it our mission to bring you news that matter about the stock you follow. Today, our research desk covers a blog story on PHG; also brushing on WATT. Go directly to your stock of interest and access today’s free coverage at:

http://protraderdaily.com/optin/?symbol=PHG

http://protraderdaily.com/optin/?symbol=WATT

The Announcement

Philips stated that over 40% of unanticipated hospital deaths happen in the General Ward, where it is hard to predict which patients to watch closely. Hence, obtaining vital signs in real-time using EWS enables clinicians to identify subtle signs of deterioration in a patient’s condition at the point of care, hours before a potential adverse event occurs. Lakeland Health first implemented Philips patient monitoring technology in June 2016, where the amount of rapid responses advanced significantly with the number of cardiac and respiratory arrests decreasing by about 56%.

Lakeland Health is a community-owned health system, which includes three hospitals, an outpatient surgery center, a cancer center, rehabilitation centers, long-term care, hospice, home care services, and physician practices. Lakeland Health views the IntelliVue Guardian Solution as a remarkable approach to eliminate potential transcription errors and also offer caregivers immediate access to patients’ vital signs, hence reducing delays in treatment time. With the assistance of Guardian Solution, the caregivers will be now well equipped with the latest information and will be notified of changes in a patient’s vital signs may put them at risk for conditions such as sepsis, cardiac arrest, or respiratory failure. Also, the frequent monitoring with automated EWS enables caregivers and Rapid Response Teams to respond earlier.

According to Philips, having automated tools that deliver a comprehensive view into a patient’s condition not only helps in identifying potential patient deterioration, but it also helps enhance workflow efficiencies by simplifying the medical documentation and better utilizing limited staff resources.

Company Growth Prospects

Philips is a leading health technology company focused on improving people’s health and offers solutions across diagnosis, treatment, and home care. The Company leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. The Company’s health technology portfolio generated net sales of EUR 17.4 billion in 2016, and currently employs about 70,000 employees with sales and services in more than 100 countries.

Prior to the announcement, on August 09, 2017, Philips completed the acquisition of The Spectranetics Corporation (NASDAQ: SPNC), a US-based global leader in vascular intervention and lead management solutions. Spectranetics observed double-digit growth according to Philips, and projects 2017 sales to be about $300 million. Philips viewed this acquisition as an expansion strategy into the EUR 6 billion Image Guided Therapy business. According to Philips, the combination of Spectranetics’ highly competitive product range and the Company’s leading portfolio of interventional imaging systems, devices, software, and services will deliver enhanced care for patients by enabling clinicians to decide, guide, treat and confirm the appropriate cardiac and peripheral vascular treatment.

Last Close Stock Review

Philips’ share price finished yesterday’s trading session at $37.82, climbing 1.56%. A total volume of 644.99 thousand shares have exchanged hands. The Company’s stock price soared 7.72% in the last three months, 29.30% in the past six months, and 33.40% in the previous twelve months. Additionally, the stock rallied 23.72% since the start of the year. Shares of the Company have a PE ratio of 29.32 and have a dividend yield of 2.27%. The stock currently has a market cap of $35.83 billion.

Pro-Trader Daily:

Pro-Trader Daily (Pro-TD) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and Canadian stocks. PRO-TD has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

PRO-TD has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email contact@protraderdaily.com. Rohit Tuli, a CFA® charter holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by PRO-TD. PRO-TD is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

PRO-TD, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. PRO-TD, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, PRO-TD, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither PRO-TD nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://protraderdaily.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: contact@protraderdaily.com

Phone number: (917) 341.4653

Office Address: Mainzer Landstrasse 50 Frankfurt am Main, Germany 60325

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Pro-Trader Daily

ReleaseID: 472891